Abbott Laboratories (ABT)
NYSE • Healthcare
May 20, 2026 at 16:00 UTC
About Abbott Laboratories
Abbott Laboratories is a healthcare company focused on diagnostics, medical devices, nutrition, and branded generic medicines. Its product offerings range from glucose monitoring systems and cardiovascular devices to infant formula and adult nutrition products. The company’s diagnostics division supplies laboratories and hospitals with testing platforms that support disease detection and management. Abbott also provides branded generics in emerging markets, expanding access to affordable healthcare. With a presence across North America, Europe, Asia, and Latin America, the company operates within the healthcare sector, supporting both developed and developing markets with products designed to improve patient outcomes and quality of life.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Abbott Laboratories's Technical Indicators Summary
Abbott Laboratories sits in a neutral technical state with contrasting signals from short-term moving averages, which are constructive, and longer-term averages, which remain higher and portray longer-term pressure. ADX signals a strong underlying trend component but OBV is negative and momentum readings are tepid, while volatility is contained and VWAP lies close to the current price. Technical takeaway: Neutral—short-term strength is offset by longer-term resistance and weak volume, producing a balanced overall view.
| Indicator | Value |
|---|---|
RSI (14) | 42.67 |
Stochastic %K (14, 3, 3) | 62.42 |
CCI (20) | -6.42 |
WPR (14) | -35.33 |
Momentum (10) | 1.51 |
MFI | 44.39 |
MACD Level (12, 26) | -3.08 |
Bollinger Bands | $81.30 - $94.58 |
ATR (14) | $2.23 (2.54%) |
ADX (14) | 47.06 |
OBV | -270,185,935 |
VWAP | $87.74 |
Classic Pivot Point | $88.52 |
Fibonacci Pivot Point | $88.52 |
Simple Moving Averages | $85.60 - $96.92(5 indicators) |
Exponential Moving Averages | $86.87 - $114.17(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
End-of-day trade saw ABT unable to fully erase the -0.51% gap down from yesterday, settling near 88.37. Into the close, ABT still showed subdued interest, with volume at 0.46× its norm. ABT fades after yesterday's gap as biosimilars push supports EPD growth, while volume remains notably subdued.
Price Change
from $88.36 close
$0
Trading Volume
Below avg (13.0M)
5.9M
vs S&P 500 Today
Underperforming Market
-1.50%
52-Week Position
Lower range
11.2%
Updated: May 20, 2026 at 20:04 UTC
Quote Summary
ABT Headlines
Abbott hit with $53 million infant formula verdict
April 10, 2026
Citi Resets Life Sciences And MedTech Views
March 11, 2026
Analysts Shift on Key Blue-Chip and Growth Names
February 8, 2026
Lam Research, Broadcom, Oracle Lead Q3 Growth Amid AI Demand
November 12, 2025